<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Hobbs Hale | Activity</title>
	<link>https://recash.wpsoul.net/members/hourlevel13/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/hourlevel13/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hobbs Hale.</description>
	<lastBuildDate>Mon, 10 Aug 2026 15:34:37 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0a5ebed2569db6d10901f0b2293cd401</guid>
				<title>Hobbs Hale posted an update: We report the first case of lichenoid eruption [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/145777/</link>
				<pubDate>Sun, 05 Jan 2025 12:31:55 +0000</pubDate>

									<content:encoded><![CDATA[<p>We report the first case of lichenoid eruption hypersensitivity reaction associated with apixaban in patient with tolerance to rivaroxaban.</p>
<p>Apixaban-induced lichenoid eruption Well documented case reports, although providing evidence of probable causal relationship between a drug and specific adverse drug reactions (ADRs), can increase&hellip;<span class="activity-read-more" id="activity-read-more-145777"><a href="https://recash.wpsoul.net/activity/p/145777/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">04a00df7e815e99b4341246f1642eead</guid>
				<title>Hobbs Hale became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/145623/</link>
				<pubDate>Sun, 05 Jan 2025 12:01:00 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>